iShares Biotechnology ETF
IBB
IBB
253 hedge funds and large institutions have $2.6B invested in iShares Biotechnology ETF in 2013 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 76 reducing their positions, and 21 closing their positions.
Holders
253
Holders Change
+21
Holders Change %
+9.05%
% of All Funds
8.21%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.39%
New
44
Increased
86
Reduced
76
Closed
21
Calls
$184M
Puts
$147M
Net Calls
+$37.3M
Net Calls Change
+$123M
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$224M |
2 |
2
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
$27.9M |
3 |
CS
3
Credit Suisse
Zurich,
Switzerland
|
$912K |
4 |
4
Allianz Asset Management
Munich,
Germany
|
$115M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$48.8M |